Anhui Anke Biotechnology (Group) Co (SZSE:300009) YoY EBITDA Growth : -33.68% (As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Anhui Anke Biotechnology (Group) Co YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Anhui Anke Biotechnology (Group) Co's YoY EBITDA Growth for the quarter that ended in Dec. 2024 was -33.68%.

Anhui Anke Biotechnology (Group) Co's EBITDA per Share for the three months ended in Dec. 2024 was ¥0.06.

Anhui Anke Biotechnology (Group) Co YoY EBITDA Growth Historical Data

The historical data trend for Anhui Anke Biotechnology (Group) Co's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anhui Anke Biotechnology (Group) Co YoY EBITDA Growth Chart

Anhui Anke Biotechnology (Group) Co Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

114.49

-19.59

136.97

9.22

-10.71

Anhui Anke Biotechnology (Group) Co Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
YoY EBITDA Growth	Get a 7-Day Free Trial															13.10	17.56	-5.96	-31.82	-33.68

Anhui Anke Biotechnology (Group) Co YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Anhui Anke Biotechnology (Group) Co's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(0.55	-	0.616)	/	\| 0.616 \|
=	-10.71 %

Anhui Anke Biotechnology (Group) Co's YoY EBITDA Growth for the quarter that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (Q: Dec. 2024 )
=	(EBITDA per Share (Q: Dec. 2024 )	-	EBITDA per Share (Q: Dec. 2023 ))	/	\| EBITDA per Share (Q: Dec. 2023 )) \|
=	(0.063	-	0.095)	/	\| 0.095 \|
=	-33.68 %

Anhui Anke Biotechnology (Group) Co YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Anhui Anke Biotechnology (Group) Co's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Anhui Anke Biotechnology (Group) Co Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anhui Anke Biotechnology (Group) Co Ltd (SZSE:300009) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

N/A

Address

No.9 Changjiang Road, Hefei High-tech Zone, Customs Road 669, Hefei, CHN, 230088

Website

http://www.ankebio.com

Anhui Anke Biotechnology (Group) Co Ltd is engaged in the development, manufacture, and sale of pharmaceuticals and health-care products. The Company distributes its product in both domestic and overseas markets. The company operates in more than 30 provinces in China.

Executives

Zhao Hui	Directors, executives
Zhou Yuan Yuan	Directors, executives
Wang Yong	Supervisors
Yao Jian Ping	Executives
Wang Rong Hai	Directors, executives
Song She Wu	Directors, executives
Fu Yong Biao	Directors, executives
Jiang Jun Pei	Supervisors
Xu Zhen Shan	Director
Lu Guang Xin	Executives
Yan Xin Wen	Executives
Lu Chun Yan	Executives
Wu Rui	Director
Fan Qing Lin	Director
Wang Yong Bin	Executives

Anhui Anke Biotechnology (Group) Co Headlines

No Headlines